PARLIAMENTARY DEBATE
Covid-19 Update - 17 May 2021 (Commons/Commons Chamber)
Debate Detail
I can report to the House that there are now fewer than 1,000 people in hospital in the United Kingdom with coronavirus, and the average number of daily deaths is now nine. This progress means we are able to take step 3 in our road map today, carefully easing some of the restrictions that we have all endured. People have missed the things that make life worth living, businesses have endured hardship and everybody has made sacrifices. While we can take this step today, we must be humble in the face of this virus. We have all learned over the past year that, in a pandemic, we must look not just at where we are today, but where the evidence shows we may be in weeks and months down the track. The vaccination programme can give us confidence, but we must be alert to new variants that could jeopardise the advances that we have made.
Today, I would like to update the House on the work we are doing to tackle variants of concern—in particular, variant B1617.2, which is the variant of concern first identified in India—so that we can protect the progress that we have worked so hard to achieve. There are now 2,323 confirmed cases of B1617.2 in the UK; 483 of these cases have been seen in Bolton and Blackburn with Darwen, where it is now the dominant strain. Cases there have doubled in the last week and are rising in all age groups. In Blackburn, hospitalisations are stable, with eight people currently in hospital with covid. In Bolton, 19 people are now in hospital with coronavirus, the majority of whom are eligible for a vaccine but have not yet had one. That shows that the new variant is not tending to penetrate into older vaccinated groups, and underlines again the importance of getting the jab—especially, but not only, among the vulnerable age groups.
In Bolton and Blackburn, we have taken the approach that worked in south London against the South African variant. We have surged in our rapid response team: 100 people so far, who visited approximately 35,000 people this weekend to distribute and collect tests. We have installed six new testing units, brought in more than 50 new vaccinators and set up two new vaccination centres, as well as extending opening hours and capacity at our existing sites. In Bolton, we have quadrupled the rate of vaccination. We carried out 6,200 vaccinations over this weekend, and it is brilliant to see so many people from the most vulnerable groups coming forward to get the protection, whether it is their first or second jab.
All in all, this is the biggest surge of resources into any specific local area that we have seen during the pandemic so far. It has been co-ordinated by Dr Jenny Harries, the chief executive of the new UK Health Security Agency, drawing on all the health capabilities, locally and nationally, that we have built in the past year. I thank everyone who is working so hard to make it happen, including everyone at the two local authorities; the rapid response team; all the volunteers, including those from St John Ambulance; and, most importantly, the people of Bolton and Blackburn for the community spirit that they are showing.
It has been really heartening, as I am sure the whole House will agree, to see the videos published over the weekend of people queuing up to get the jab. I say to anyone who feels hesitant about getting the vaccine, not just in Bolton or Blackburn, but right across the country: just look at what is happening at the Royal Bolton Hospital. The majority of people in hospital with coronavirus were eligible for the jab but had chosen not yet to have it, and have ended up in hospital—some of them in intensive care. Vaccines save lives. They protect you, they protect your loved ones and they will help us all get out of this pandemic.
This is not just about Bolton and Blackburn. There are now 86 local authority areas where there are five or more confirmed cases. The next biggest case of concern is Bedford, where we are surging testing. I urge everybody in Bedford to exercise caution and engage in testing where it is available.
I also want to tell the House the latest scientific assessment of this variant. The early evidence suggests that B1617.2 is more transmissible than the previously dominant B1117 variant. We do not yet know to what extent it is more transmissible. While we do not have the complete picture of the impact of the vaccine, the early laboratory data from Oxford University corroborates the provisional evidence from the Royal Bolton Hospital and the initial observational data from India that vaccines are effective against the variant. This, of course, is reassuring, but the higher transmission poses a real risk.
All this supports our overriding strategy, which is gradually and cautiously to replace the restrictions on freedom with the protections from the vaccines. The data suggests that the vaccine has already saved more than 12,000 lives and prevented more than 33,000 people from being hospitalised, and we are protecting people at a very rapid pace. Last week was the biggest week of vaccinations since the end of March. Some 36 million people have now had a first dose, and yesterday we reached the milestone of 20 million people across the UK having had their second dose.
I am delighted to see the figures released by YouGov today, which show that the UK has the highest vaccination enthusiasm in the world, with 90% of people saying that they have had or will have the jab. This was no accident. We began planning the campaign for vaccine uptake a year ago. I thank the huge range of people involved in promoting the benefits of vaccination, from Her Majesty the Queen to Sir Elton John, Harry Redknapp, Lenny Henry, Holly Willoughby, Lydia West and many, many others. Our campaign has been based on positivity and science, and I am grateful to everybody who has played their part.
I can confirm that from tomorrow we will be inviting people aged 37 to come forward, before expanding this further later in the week. It has been brilliant to see people’s enthusiasm when they have been invited to come forward, and we want to make it as easy as possible for them to show that they have had the protection the vaccine provides. I am delighted to say that, as of today, people can demonstrate whether they have had their jab, quickly and simply, through the NHS app.
Since January, we have been following a dosing interval of 12 weeks for second doses. Because of the extra protection people get from the second dose, particularly among those most likely to end up in hospital or dying, it is incredibly important that everyone comes forward for that second dose at the right moment. The approach we have taken aims to give the most vulnerable the strongest possible protection against this virus. Since January, that has meant getting the first dose to as many people as possible, as quickly as possible. The research shows that this approach has saved about 12,000 lives.
Now, it is important to accelerate the second doses for all those most vulnerable to ending up in hospital or dying. Our vaccination strategy for all parts of the UK, including the areas of surge vaccination, will therefore stick by the clinical advice set out by the Joint Committee on Vaccination and Immunisation: first, prioritise anyone over 50 who has not yet been vaccinated; next, second doses to those over 50 are vital—that will now be done on a schedule of eight weeks; and, then, follow the cohorts in priority order, and the age groups as we open them. This clinically approved approach is the best way to save the most lives, rather than jumping ahead with first doses for younger people. Although the JCVI of course keeps this under constant review, we are clear that its advice is the best way to protect those most in need of protection and so save as many lives as we can. The NHS will be reiterating this advice to all vaccination centres and all directors of public health, and I am very grateful to everyone, in the NHS, local authorities and in the whole system supporting this vaccination programme, for following it.
Today’s opening and step 3 marks an important step on our road to our recovery. We must proceed with caution and care, and bear down on the virus, in whatever form it attacks us, so that in this race between the vaccine and the virus, our humanity, science, and ingenuity will prevail. I commend this statement to the House.
Yesterday, the Secretary of State warned on the television that the B.1617.2 variant could “spread like wildfire” among the unvaccinated, but does he accept that we could have avoided this? Our borders have been about as secure as a sieve, and the delay in adding India to the red list surely now stands as a catastrophic mis-step. One month ago in this House, I urged him to act quickly in response to this variant. The Wellcome Sanger Institute data today shows a rapid increase in this variant, to 30% of all sequenced cases in the UK, and that excludes cases from travel and surge testing. Alarm bells should be ringing, because although the Secretary of State offers reassurance that vaccines are effective, we have also heard Professor Anthony Harnden of the JCVI recently warn us that vaccines are “almost certainly less effective” at reducing the transmission of this variant.
I entirely appreciate that when questioned I suspect that the Secretary of State will not be able to give a cast-iron assurance about opening up on 21 June, and I am not going to try to push him into a corner; we all understand that we are dealing with uncertainties and we have to be grown up about these things. But we do need a plan now to contain this variant urgently. He is said to be considering local lockdowns. As he knows, I speak as a resident of long locked-down Leicester. Before he takes out his mallet to try to whack moles again, may I suggest a number of things for him to try first?
First, will he consider surge vaccination in all hotspot areas and go hell for leather to roll out vaccinations to everyone? I listened very carefully to what he said about vaccination increases in Bolton, and I hope that also includes Blackburn. Is he saying that everyone over 18 in those areas will now be eligible for vaccination? As he knows, that is something that public health directors on the ground have been calling for, and I hope we listen to them.
We have had these debates in the House before, and the Secretary of State knows that even if we drive up vaccination as high as it can possibly go among adults, there are still about 20% of the wider population—children —who remain unvaccinated, which means the virus can still spread. The Centers for Disease Control and Prevention in the US are moving to vaccinate children. Will he update us on what progress he is making on that front here? On children, the Secretary of State knows that in many secondary schools, mask wearing is no longer necessary. Will he assure us that he thinks that is the right response in the light of the data he unveiled today?
Secondly, the Secretary of State has announced extra surge testing, but he knows by now that surge testing must be backed up by proper sick pay and decent isolation support. That should have been fixed in the Queen’s Speech last week.
Thirdly, more venues are opening up today. Many will be spending a lot of time disinfecting surfaces, like we do in here, which is good and important, but we know so much more about this virus now. We know about airborne spread of the virus, so why are we not supporting venues more with ventilation? What are we doing to help supermarkets, shopping centres and larger venues where air circulates around the building to put in place covid-secure air filtration systems?
Fourthly, what the Secretary of State said about the NHS and the uptake of beds is welcome, but NHS staff, as he knows, are exhausted and fear another surge. What modelling has been shared with NHS leaders, and what are they doing to prepare for any surge in admissions?
Finally, the surge in this variant reminds us that we are not safe until everyone is safe. That is not a slogan; it is a fact. Some 3.3 million lives have been lost globally to this virus, and Dr Tedros Adhanom Ghebreyesus from the World Health Organisation warns that we are on track for the second year of this pandemic to be far more deadly than the first. Only 0.3% of vaccine supply is going to low-income countries. Trickle-down vaccination is not an effective strategy for fighting this deadly virus. Not only do we have a moral responsibility to play our part internationally, but that also reduces the risk of new variants bouncing back at us and setting us back.
At this critical time, when we need to work internationally to defeat this virus, why are we the only G7 nation cutting its aid budget? How can the Secretary of State defend cutting our contribution to vital science and research projects? Given the total silence from the Government on President Biden’s support for the temporary lifting of patent protections to increase vaccine production, should we assume that the Government do not agree with President Biden?
We are also making sure we have the vaccines available, but I want to be absolutely crystal clear about the approach to vaccination. The hon. Gentleman asked about vaccinating all over-18s in Bolton and Blackburn, but that is not our approach. I have looked into it in great detail, and we have taken clinical advice. The approach is to make sure that we get done as many second vaccinations as possible, as many first vaccinations as possible among the vulnerable groups, and then as many vaccinations as possible among those aged under 50 in the eligible groups. We have taken that approach because that is what is likely to save most lives. That second jab is vital. The first jab for anybody over 50 could mean the difference between life and death. The very strong focus is to get the vaccine to all those over 50 who have not yet taken the first jab. I am glad to say that reports from both Bolton and Blackburn suggest that uptake among people who are eligible, but who have not yet taken the jab, has increased since we saw the rise of the B1617.2 variant in those areas. It is effective in proving to people that the jab really does work to protect them. That is what the data shows.
The hon. Gentleman asked about children. I have been closely following the results of the clinical studies from Pfizer that show that the vaccine is safe and effective among children between the ages of 12 and 18. We have procured enough Pfizer to be able to offer that jab to children should that be clinically approved here, but given that we are at the stage of opening tomorrow to people aged 37, there is some time to go before we get to 18-year-olds. We are on track to meet the target of offering the vaccine to all those aged 18 and above by the end of July, so we have a couple of months before we need to make and operationalise a decision. We want to be very, very careful and sensitive about whether and how we offer the vaccine to children.
The hon. Gentleman asked about important wider measures. He mentioned ventilation. We have put in place guidance for businesses in terms of strengthening the rules around ventilation, and that, too, is important. He did a bit of a Captain Hindsight act on the Indian variant. He did not seem to mention that we put India on the red list before this variant was even deemed a variant under investigation, let alone a variant of concern. Indeed, we put India on the red list before countries such as Germany and Canada stopped flights from India. We have a strong policy of restrictions at the border and we will remain vigilant.
The final point to which I wanted to respond was on the global moral responsibility to vaccinate everybody in the world. The hon. Gentleman is absolutely right that we have a global moral responsibility. I argue that, thus far, the United Kingdom has done, and will continue to do, more than any other nation. It is about not just the huge sums that we have put into COVAX, but the way that we delivered the Oxford-AstraZeneca vaccine around the world. As of this morning, 1.47 billion vaccines have been delivered globally, 400 million of which have been the Oxford-AstraZeneca vaccine. AstraZeneca has charged a profit margin and a margin for intellectual property of zero—no charge for intellectual property, no profit for AstraZeneca. Costs, of course, need to be met, but we have taken nothing for the money that we put into the vaccine’s development. This is the biggest gift that this country could give to the world. A total of 65% of those 400 million doses have been delivered into the arms of people in low and middle-income countries, including more than 150 million in India. On the COVAX facility, which is the biggest global effort to vaccinate in low and middle-income countries, it has delivered 54 million vaccines so far, 53 million of which have been done with the Oxford-AstraZeneca vaccine.
This country can be hugely proud of the contribution it has made. It is far bigger so far than that of any other country. We took the view from the start that we do not need to change our IP rules, we do not need to change the law, we just need to get on and get the vaccine out to as many people around the world as possible, at cost. Everybody in this House should be very, very proud of what AstraZeneca and Oxford University have done with the support of the UK Government. That is how we save lives around the world.
The Scientific Advisory Group for Emergencies has stated that evidence shows that the B1617.2 Indian variant is up to 50% more infectious than the Kent variant and has advised that, as in Scotland, areas with rising numbers of cases should remain under covid restrictions. The Indian variant has been doubling every week despite lockdown, so why is the Secretary of State ignoring SAGE advice and opening up areas like Bolton that have exponential growth?
Thankfully, the Indian variant does not show significant vaccine resistance, but the Secretary of State must know that it is not possible to outrun the virus through vaccination alone. As those aged up to 35 are not eligible for surge vaccination, that leaves a large pool of unvaccinated people among whom the variant can spread. It will take two to three weeks before even those who receive a vaccine in the coming weeks are protected. Does the Secretary of State not accept that the variant is in danger of surging and that without local travel restrictions it will spread to other areas? It is good news that fully vaccinated people are not ending up in hospital, but just letting the virus spread among young adults could allow the evolution of yet another UK variant.
When it comes to how we are tackling the virus in the UK, the hon. Lady is quite right that it is good news—albeit early news—that the vaccines do appear to be effective against the B1617.2 variant. I am obviously pleased about the evidence we have seen but we are vigilant about that. I am glad that the approach we are now taking in Bolton and Blackburn worked against the South African variant in south London. We always keep these things under review, but I think that as a first resort, surge testing, going door to door, ensuring that we find and seek out the virus wherever we can spot it, and putting in the extra resources with the armed services who are supporting us, are the right approaches while we keep this under review. The numbers thus far nationally are still relatively low and, thankfully, we have a very good surveillance operation across the UK so that we can spot these things early and take the action that we need to.
It is incumbent on us all to communicate these messages from our scientists and to make sure that people understand them. I am pretty sure that the British public get that. Given how brilliantly people have responded to requests during the pandemic, I am highly confident that this approach will be successful and that people will be cautious, but enjoy the new freedoms that we are thankfully able to give.
I pay tribute to all those my hon. Friend mentioned. Councillor David Greenhalgh, the leader of Bolton Council, has worked incredibly hard, as have his whole team. We are working cohesively together, and I very much hope that with that effort, we can get this sorted.
I understand my hon. Friend’s broader point, which is a call against local lockdowns, and we have had differences of view on that in the past. It is not where we want to go, though of course we do not rule it out. We have seen our approach work—it worked in south London —and we have this huge testing capacity, which we did not have in the autumn, of hundreds of thousands of tests a day. That capacity is expanding, as the hon. Member for Warwick and Leamington (Matt Western) articulated. We also have millions of lateral flow tests, which are simple and easy to use, and people get the result fast. With surge testing plus the vaccine, we have many more tools in our armoury than we did before.
The Secretary of State indicated that probably a significant factor in the spread of the highly transmissible new variant is that people who could have been vaccinated by now chose, for whatever reason, not to accept the vaccine. In a number of cases, people have genuine concerns, but a major issue must be that people are declining the vaccine because they believe the lies deliberately and maliciously spread by anti-vax campaigners on social media. What further action do the Government wish to take against those who deliberately spread those lies for no other purpose than to put the lives of others at risk?
I am very grateful to the hon. Gentleman for playing his part in that by celebrating having his second jab. I am thrilled that he will have, in just a couple of weeks’ time, the maximum protection that one can get. He is helping not only himself and his loved ones, but all of us together to get through this.
I urge the hon. Lady to speak to her colleagues in the local NHS, and ask them whether they think that collaboration is the way forward; whether we should have greater interoperability; and whether we should have greater integration on the ground, and get rid of a load of the bureaucracy that is currently there in law. If she is not persuaded by her local NHS, by me or by the Select Committee, perhaps she should speak to her own Front Benchers, who also welcomed the reforms.
My hon. Friend is quite right to raise this point about the Novavax vaccine, which is going to be manufactured on Teesside. Of course, we will study its impact against the new variants, but we have a high degree of confidence that the Novavax vaccine has a broad coverage. In fact, one of its attractions is that it has that broad coverage, not just against the variant that it was precisely designed to deal with but against a wide range of variants. That is part of the theory of the technology that underpins that particular vaccine. It is a very modern vaccine, it is very exciting, and it is terrific that it is being made on Teesside.
I reiterate the point I made earlier, which I hope the hon. Gentleman will take pride in: of the 54 million vaccine doses delivered through the COVAX facility, of which we are a major funder, 53 million have been of the Oxford-AstraZeneca vaccine, delivered with no charge for the intellectual property. That is the approach we should be taking. That is what we will do, and I urge everybody around the world to follow.
Up until 6 o’clock yesterday, flights were still coming into the UK from India, and 20,000 people have arrived in the UK since the alarm was raised about that variant. Does the Secretary of State really want to look Glaswegians in the eye and say that that was decisive action that has led to their staying in tier 3?
On global support, of course as and when we have excess doses we will look to support countries around the world with those doses, but the number of doses that we can support around the world from our excess purchases is small compared with the spectacular support we have already given the whole world with the more than 400 million doses of Oxford-AstraZeneca vaccine that have been delivered at cost. The majority of Oxford-AstraZeneca doses have been injected in low and middle-income countries, and 98% of all COVAX jabs given so far have been that vaccine delivered on the back of British science, supported by the UK Government, Oxford university and AstraZeneca, doing this all without taking a profit. We should be very proud of that.
We are inviting people who are over 50 and have a second jab booked 12 weeks after their first to rebook their vaccination from eight weeks after—not before eight weeks, because the effectiveness of the second jab strengthens for those first eight weeks. They can do that on the national booking system or through calling 119. We are texting those whose numbers we have to communicate with them. There is a whole process in place to get people rebooked wherever possible.
On the ground, there are some really good examples. I mentioned my visit to Brent central mosque and I pay tribute to the people there. Some brilliant work has happened in Leicester; for instance, there was a vaccination centre right next to an area heavily populated by those of Somali background, but they were not going to the vaccination centre despite the fact that it was next door and so we set up a vaccination centre almost next door but where the doctors and clinicians are themselves Somalis. We then we saw a very sharp rate in the Somali vaccination rate. That is one example that I can immediately add to the elucidation of the answer to this question, but there are legion. People from around the world have been coming, via Zoom, to talk to some of our more innovative vaccination centres, be it at the mosque, at the Hindu temple in Neasden, which is doing brilliant work, in Leicester or, now, in Bolton and Blackburn, where I hope we can make some really significant progress. Frankly, this country should be proud of how people have pulled together to make this vaccination programme work.
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.